Efficacy and Safety of Orally Administered DS102 in Patients With Acute Alcoholic Hepatitis
Public ClinicalTrials.gov record NCT03452540. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomised, Double-Blind, Placebo-Controlled, Phase II Study to Assess the Efficacy and Safety of Orally Administered DS102 in Patients With Acute Decompensated Alcoholic Hepatitis.
Study identification
- NCT ID
- NCT03452540
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Afimmune
- Industry
- Enrollment
- 9 participants
Conditions and interventions
Interventions
- 1000mg DS102 (BID) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 27, 2018
- Primary completion
- Jun 18, 2019
- Completion
- Mar 30, 2020
- Last update posted
- Jul 28, 2022
2018 – 2020
United States locations
- U.S. sites
- 6
- U.S. states
- 5
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Schiff Center for Liver Diseases (University Hospital Miami) | Miami | Florida | 33136 | — |
| Cleveland Clinic Florida | Miami | Florida | 33331 | — |
| Kansas University Medical Center | Kansas City | Kansas | 66160 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Bon Secours Liver Institute of Richmond and Bon Secours Liver Institute of Hampton Roads | Newport News | Virginia | 23602 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03452540, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 28, 2022 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03452540 live on ClinicalTrials.gov.